A Modeling Study Recurrent Tuberculosis Towards End TB Strategy - China, 2025-2035.

Abstract

What is already known about this topic?: The recurrence of tuberculosis (TB) following successful treatment presents a significant challenge.

What is added by this report?: Achieving the global End TB Strategy milestones and targets with the current strategies in China is challenging. However, interventions following recovery to prevent recurrence, in conjunction with preventive treatment for latent TB infection (LTBI), will aid in meeting these objectives.

What are the implications for public health practice?: Implementing interventions to mitigate recurrence is essential for improving TB control strategies both in China and worldwide. Concurrently, the development of new drugs and vaccines should focus on preventing TB recurrence.